Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Year-over-year research & development expense growth
5Y CAGR
+11.7%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 75.25% |
| 2024 | 0.00% |
| 2022 | 17.91% |
| 2021 | -7.60% |
| 2020 | -14.51% |
| 2019 | 43.22% |
| 2018 | 48.18% |
| 2017 | 382.51% |
| 2016 | 0.00% |